Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Acasti, Enzymotec, Neptune Technologies nutraceuticals news

    Acasti Pharma Inc. (TSX-V:APO; NASDAQ:ACST), Laval, Quebec Enzymotec Ltd. (NASDAQ:ENZY), Migdal HaEmeq, Israel Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT; TSX:NTB), Laval, Quebec Business: Nutraceuticals The…

    Published on 5/5/2014
  • Affiris, Biolution GmbH, Forschungszentrum Juelich GmbH, French Clinical Research Infrastructure Network (F-Crin), Medical University Innsbruck, Prosenex Ambulatorium Betriebs GmbH, University ...

    Affiris AG, Vienna, Austria Biolution GmbH, Vienna, Austria Forschungszentrum Juelich GmbH, Juelich, Germany French Clinical Research Infrastructure Network (F-Crin), Toulouse, France Medical University Innsbruck, …

    Published on 5/5/2014
  • Affymetrix, Enzo supply/service news

    Affymetrix Inc. (NASDAQ:AFFX), Santa Clara, Calif. Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Business: Supply/Service Affymetrix will pay Enzo $5.1 million to settle two breach of contract cases in the U.S. …

    Published on 5/5/2014
  • Alere, Malaria No More diagnostic news

    Alere Inc. (NYSE:ALR), Waltham, Mass. Malaria No More, New York, N.Y. Business: Diagnostic Alere delivered 1 million Alere SD BIOLINE Malaria Rapid tests to Zambia through Malaria No More's Power of One Campaign. As …

    Published on 5/5/2014
  • ALS investment fund neurology news

    ALS investment fund, Amsterdam, the Netherlands Business: Neurology Three entrepreneurs diagnosed with amyotrophic lateral sclerosis (ALS) launched a for-profit investment fund for ALS translational research. The fund …

    Published on 5/5/2014
  • Ariosa Diagnostics, Illumina diagnostic news

    Ariosa Diagnostics Inc., San Jose, Calif. Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Diagnostic Illumina filed suit in the U.S. District Court for the Northern District of California alleging that Ariosa's…

    Published on 5/5/2014
  • Avanir, Impax, Par Pharmaceutical neurology news

    Avanir Pharmaceuticals Inc. (NASDAQ:AVNR), Aliso Viejo, Calif. Impax Laboratories Inc. (NASDAQ:IPXL), Hayward, Calif. Par Pharmaceutical Cos. Inc., Woodcliff Lake, N.J. Business: Neurology A judge in the U.S. District …

    Published on 5/5/2014
  • Biota Pharmaceuticals, U.S. Department of Health and Human Services infectious news

    Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Alpharetta, Ga. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Biota reported that HHS's Office of the Assistant Secretary for Preparedness …

    Published on 5/5/2014
  • Diaxonhit, InnaVirVax, Institut National de la Sante et de la Recherche Medicale (INSERM) infectious, diagnostic news

    Diaxonhit (Euronext:ALEHT), Paris, France InnaVirVax S.A., Evry, France Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, France Business: Infectious, Diagnostic InnaVirVax said it will receive …

    Published on 5/5/2014
  • Galena Biopharma, MD Anderson Cancer Center, U.S. Department of Defense cancer news

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. MD Anderson Cancer Center, Houston, Texas U.S. Department of Defense, Washington, D.C. Business: Cancer The Department of Defense awarded the cancer center an …

    Published on 5/5/2014
  • Sinovac infectious news

    Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Sinovac said it was awarded a RMB60 million ($9.6 million) grant to construct a production facility for its human enterovirus 71 (EV71) vaccine …

    Published on 5/5/2014
  • Teva, Actavis, Mylan, Pfizer gastrointestinal news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Actavis plc (NYSE:ACT), Dublin, Ireland Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Gastrointestinal …

    Published on 5/5/2014
  • Bavarian Nordic, U.S. Department of Health and Human Services infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Bavarian Nordic said HHS's Biomedical Advanced Research and Development Authority (…

    Published on 4/28/2014
  • Boehringer Ingelheim biosimilars news

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Biosimilars Boehringer Ingelheim disclosed that it is conducting Phase III trials evaluating biosimilars of autoimmune drug Humira adalimumab, cancer drug Avastin …

    Published on 4/28/2014
  • Celgene, Stryker, Sanofi other news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Stryker Corp. (NASDAQ:SYK), Kalamazoo, Mich. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Other Judge Katharine Hayden for the U.S. District Court for the District …

    Published on 4/28/2014
  • Danco Laboratories LLC genitourinary news

    Danco Laboratories LLC, New York, N.Y. Business: Genitourinary Oklahoma Gov. Mary Fallin signed into law a bill that prohibits off-label use of Danco's Mifeprex mifepristone (RU-486), which is indicated for the medical …

    Published on 4/28/2014
  • Eli Lilly, J&J, Merck, Roche cancer, autoimmune news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer,…

    Published on 4/28/2014
  • Endo, Hisamitsu, Teikoku Seiyaku, TWi Pharmaceuticals neurology news

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530), Tosu, Japan Teikoku Seiyaku Co. Ltd., Higashikagawa, Japan TWi Pharmaceuticals Holding Inc. (GreTai:4180), …

    Published on 4/28/2014
  • Endofotonics, National University of Singapore diagnostic news

    Endofotonics Pte. Ltd., Singapore National University of Singapore, Singapore Business: Diagnostic The university spun off newco Endofotonics, which is developing its IMDX molecular diagnostic system for instant cancer …

    Published on 4/28/2014
  • Genetic Technologies, ImmunAid Ltd. other news

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia ImmunAid Ltd., Fitzroy, Australia Business: Other At an extraordinary general meeting, Genetic shareholders approved a deal in which founder Mervyn …

    Published on 4/28/2014
  • Teva autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune The U.S. Supreme Court denied a motion from Teva to stay an appeals court ruling that will end exclusivity for the biotech's …

    Published on 4/28/2014
  • XenoPort autoimmune, neurology news

    XenoPort Inc. (NASDAQ:XNPT), Santa Clara, Calif. Business: Autoimmune, Neurology XenoPort investor Clinton Relational Opportunity Master Fund L.P. has nominated a slate of three directors to the biotech's board to …

    Published on 4/28/2014
  • Zogenix neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Massachusetts Gov. Deval Patrick said doctors are now required to check a patient's controlled-substance history through a statewide prescription …

    Published on 4/28/2014
  • Applikon Biotechnology biomanufacturing news

    Applikon Biotechnology B.V., Delft, the Netherlands Business: Biomanufacturing Applikon launched a new production facility in Guangzhou, China. The company said the facility will provide a range of bioreactor systems, …

    Published on 3/24/2014
  • Arrowhead, Calando drug delivery, cancer news

    Arrowhead Research Corp. (NASDAQ:ARWR), Pasadena, Calif. Calando Pharmaceuticals Inc., Pasadena, Calif. Business: Drug delivery, Cancer Arrowhead said that subsidiary Calando ceased day-to-day operations after it …

    Published on 3/24/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993